Aurinia’s Phase 2 trial evaluates voclosporin ophthalmic solution for treating dry eye syndrome
Can't see this email? View it online
   
  August 2, 2018  
  Ophthalmology / Optometry  
  The latest ophthalmology / optometry news from News Medical  
 Aurinia’s Phase 2 trial evaluates voclosporin ophthalmic solution for treating dry eye syndromeAurinia’s Phase 2 trial evaluates voclosporin ophthalmic solution for treating dry eye syndrome
 
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the global immunology market, today announced the initiation of its Phase 2 trial evaluating voclosporin ophthalmic solution (VOS) for the treatment of dry eye syndrome (DES).
 
   Gene regulator associated with protein pileup in exfoliation glaucomaGene regulator associated with protein pileup in exfoliation glaucoma
 
In exfoliation glaucoma, a protein dandruff clogs the outflow pathway for the fluid in our eyes.
 
   People who regularly eat oranges less likely to develop macular degeneration, study showsPeople who regularly eat oranges less likely to develop macular degeneration, study shows
 
A new study has shown that people who regularly eat oranges are less likely to develop macular degeneration than people who do not eat oranges.
 
 Scientists move one step further in developing eye drops to treat age-related macular degeneration
 
Scientists move one step further in developing eye drops to treat age-related macular degenerationScientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionize treatment for age-related macular degeneration.
 
 
 Researchers investigate recessive genetic disorder that leads to childhood blindness
 
Researchers investigate recessive genetic disorder that leads to childhood blindnessOur genome is made up of 20,000 genes, all of which may cause disease. At present, 4,141 genes have been identified as being responsible for genetic abnormalities, leaving around 16,000 genes with unknown implication in disease.
 
 
 Tips on making a smooth transition to optimal eye care
 
Tips on making a smooth transition to optimal eye careIf you have glaucoma, you're wondering: What will my new ophthalmologist need to hit the ground running and manage my disease? In my experience, to make a smooth transition to optimal care, the most important thing you can do is create a personal Glaucoma Data Portfolio.
 
 
 Turmeric derivative could be used in eye drops to treat early stages of glaucoma
 
Turmeric derivative could be used in eye drops to treat early stages of glaucomaA derivative of turmeric could be used in eye drops to treat the early stages of glaucoma, finds a new study led by UCL and Imperial College London researchers.